“Clinical and Metabolic Determinants of Hepatic Fibrosis in Patients with Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) – Insights from a Bangladeshi Cohort”, The Insight, vol. 8, no. 03, pp. 588–592, Dec. 2025, doi: 10.5281/zenodo.18014065.